(Q39687020)

English

Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir

scientific article published on 10 June 2016

Statements

Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir (English)
Christoph Sarrazin
Evguenia S Svarovskaia
Diana M Brainard
John G McHutchison
Michael D Miller

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit